ARCHIVES

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

July 25, 2003

AACR, ASCO, ONS Flex Political Muscles, Seek Changes In Cancer Act, Other Legislation, Funding Of Grants

May 7, 1982

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

Moffitt Ends Pilot Study Based On Duke Test, Says Action Unrelated

October 23, 2009

Abstract Of Papers From ACTR Meeting

October 22, 1976

Review Group Report: NCI Role In Drug Development Seen As Information Provider

November 6, 1998